Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jörg Rademann has a total of 542 co-authors. Here are the top co-authors by number of shared publications:

  • Christoph Arkona

    Institute of Pharmacy, Medicinal Chemistry Freie Universität Berlin Königin-Luise-Str. 2+4 14195 Berlin Germany

    22 shared publications
  • Günther Jung

    Institute of Organic Chemistry, University of Tübingen, Tübingen, Germany

    15 shared publications
  • Sebastian Köhling

    Institute of Pharmacy , Freie Universität Berlin , Berlin D-14195 , Germany

    12 shared publications
  • Gerhard Wolber

    Molecular Design Group, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy Freie Universität Berlin Berlin Germany

    11 shared publications
  • Michael Lisurek

    Department of Medicinal Chemistry, Leibniz Institut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, 13125, Berlin, Germany

    10 shared publications
  • Christoph Nitsche

    Research School of Chemistry, Australian National University, Canberra 2601, ACT, Australia

    9 shared publications

Latest Publications

  • Open Access

    Synthesis and characterization of l -3-(pentafluorophosphato-difluoromethyl)-alanine, a structural and functional mimetic of phosphoserine

    by Anna Magdalena Ambros, Niklas Limberg, Katrin Denzinger, Markus Tiemann, Gerhard Wolber, Sebastian Riedel, Jörg Rademann

    Serine phosphorylation is an essential switch for regulating the interactions and functions of many disease-related proteins. Accordingly, stable phosphoserine mimetics constitute chemical tools to study the effects of these post-translational modifications. In this work, we present the synthesis and characterization of a novel structural analog of phosphoserine, L-3-(pentafluorophosphato-difluoromethyl)-alanine. The hyper-fluorinated amino acid was synthetically accessed in six steps starting from commercially available N-Boc-L-serine methyl ester. The protected PF5 amino acid and peptides derived thereof were inhibitors of the serine protein phosphatase PPP2CA, demonstrating its activity as functional phosphoserine mimetic.

  • Open Access

    Pentafluorophosphate-analogs of bisphosphonates as structural pyrophosphate mimetics: synthesis and characterization

    by Anna Magdalena Ambros, Stefan Sander, Rubén Cruz, Hana Zupan, Bettina G Keller, Joachim Heberle, Thomas Braun, Jörg Rademann

  • Open Access

    Genetische Codierung von Pentafluorphosphato‐Phenylalanin ermöglicht die Herstellung von PF 5 ‐Proteinen als Phosphoprotein‐Mimetika

    by Anna Magdalena Ambros, Haocheng Qianzhu, Markus Tiemann, Edan Habel, Katrin Denzinger, Hana Zupan, Matteo Accorsi, Bettina G. Keller, Gerhard Wolber, Thomas Huber, et al.

    Kurzzusammenfassung: Die Phosphorylierung von Proteinen ist eine der wichtigsten posttranslationalen Modifikationen, die Struktur, Stabilität und Aktivität von mehr als 13.000 menschlichen Proteinen beeinflusst. In dieser Arbeit wurde das Phosphotyrosin‐Mimetikum Pentafluorphosphato‐difluormethyl‐phenylalanin (PF 5 CF 2 Phe) genetisch codiert und in drei verschiedene Proteine eingebaut. Durch das Screening zweier Bibliotheken orthogonaler Aminoacyl‐tRNA‐Synthetasen konnten Enzyme identifiziert werden, die eine effiziente und spezifische Inkorporation von PF 5 CF 2 Phe in rotes Fluoreszenzprotein (RFP) über die Unterdrückung des Amber‐Stoppcodons ermöglichten. Zwei Modellproteine, humanes Ubiquitin (Ubq) und die B1‐Immunoglobulin‐Bindungsdomäne des Streptokokken‐Proteins G (GB1), wurden mit PF 5 CF 2 ‐Mutationen versehen und auf potenzielle Interaktionspartner hin untersucht. Während das native GB1 keine Bindung an Protein‐Tyrosin‐Phosphatasen (PTP) zeigte, war PF 5 ‐GB1, das PF 5 CF 2 Phe an Position 17 trägt, ein potenter Inhibitor der Phosphatasen PTP1B und SHP2. PF 5 ‐Ubq wurde hergestellt und in das erste Beispiel eines Proteins überführt, welches das bekannteste Phosphotyrosin‐Mimetikum, Phosphono‐Difluormethyl‐Phenylalanin (PO 3 CF 2 Phe), trägt. Angesichts des wachsenden Bedarfs die Funktionen komplexer Phosphorylierungsmuster zu verstehen, eröffnet die genetische Codierung von PF 5 CF 2 Phe zur Herstellung von Phosphoprotein‐Mimetika einzigartige Möglichkeiten für präzise Funktionsstudien, bei denen spezifische und homogene Proteinmodifikationen erforderlich sind.

  • Open Access

    Genetic Encoding of Pentafluorophosphato‐Phenylalanine Provides PF 5 ‐Proteins as Phosphoprotein Mimetics

    by Anna Magdalena Ambros, Haocheng Qianzhu, Markus Tiemann, Edan Habel, Katrin Denzinger, Hana Zupan, Matteo Accorsi, Bettina G. Keller, Gerhard Wolber, Thomas Huber, et al.

    Protein phosphorylation is one of the most important posttranslational modifications altering the structure, stability, and activity of more than 13 000 human proteins. In this work, the phosphotyrosine mimetic pentafluorophosphato‐difluoromethyl‐phenylalanine (PF 5 CF 2 Phe) was genetically encoded and incorporated into three different proteins. Screening two libraries of orthogonal aminoacyl‐tRNA synthetases identified enzymes enabling the efficient and specific incorporation of PF 5 CF 2 Phe into red fluorescent protein (RFP) via amber stop codon suppression. Two model proteins, human ubiquitin (Ubq) and the B1 immunoglobulin‐binding domain of streptococcal protein G (GB1), were prepared with PF 5 CF 2 Phe mutations and investigated for potential interaction partners. While native GB1 showed no binding to protein tyrosine phosphatases (PTP), PF 5 ‐GB1, with PF 5 CF 2 Phe at position 17, was a strong inhibitor of the phosphatases PTP1B and SHP2. PF 5 ‐Ubq was produced and converted into the first example of a protein carrying the most prominent phosphotyrosine mimetic, phosphono‐difluoromethyl phenylalanine (PO 3 CF 2 Phe). With increasing need in the biosciences to delineate the functions of complex phosphorylation patterns, genetic encoding of PF 5 CF 2 Phe yielding phosphoprotein mimetics opens unique opportunities for precise functional studies where site‐specific and homogeneous protein modifications are required.


  • Open Access

    Synthesis and characterization of L-3-(pentafluorophosphato-difluoromethyl)-alanine, a structural and functional mimetic of phosphoserine

    by Anna Magdalena Ambros, Niklas Limberg, Katrin Denzinger, Markus Tiemann, Gerhard Wolber, Sebastian Riedel, Jörg Rademann

    In this work, we present the synthesis and characterization of a novel structural analog of phosphoserine, L-3-(pentafluorophosphato-difluoromethyl)-alanine. The hyper-fluorinated, permanently anionic amino acid residue was synthetically accessed in six steps starting from commercially available N-Boc-L-serine methyl ester and showed biological activity as an inhibitor of the protein serine phosphatase PPP2CA, demonstrating its potential as phosphoserine biomimetic.

  • Open Access

    Metal‐Mediated Il‐8 Binding to Heparan Sulfate Evaluated by Electrochemical Impedance Spectroscopy

    by Ariel Shitrit, Israel Alshanski, Karin Mor, Jörg Rademann, Raghavendra Kikkeri, Mattan Hurevich, Shlomo Yitzchaik

    Heparan sulfate (HS) interactions with interleukin 8 (IL‐8) are crucial for immune system response. The structural features of the HS and the environmental entities, such as metal ions, can regulate these interactions. However, it is challenging to evaluate the effect of each parameter on the interactions because of low accessibility to well‐defined saccharides and the lack of characteristic features to be determined by analytical tools. We evaluated the effect of the HS structural features on IL‐8 binding affinity utilizing electrochemical impedance spectroscopy (EIS) and X‐ray photoelectron spectroscopy (XPS). We showed that the metal ions Ca2+ and Mg2+ dissimilarly mediate the interactions of HS and IL‐8 in structure‐dependent manner of the HS. We showed that in all glycans, a positive synergistic effect on IL‐8 binding was observed. For several glycans, the presence of ions resulted in a dramatic increase in the affinity to IL‐8, while for other glycans, a milder effect was observed. This demonstrated that both structural motifs and environmental features are crucial for maintaining the interactions between the HS and IL‐8.


  • Open Access

    Chemisch stabile Diazopeptide als selektive Sonden für Cysteinproteasen in lebenden Zellen

    by Juliane Wahl, Ahsanullah, Hana Zupan, Franziska Gottschalk, Andreas Nerlich, Christoph Arkona, Andreas C. Hocke, Bettina G. Keller, Jörg Rademann

    Von Diazopeptiden wurden schon früher berichtet, sie haben aber aufgrund ihrer hohen Reaktivität bis heute kein breites Einsatzgebiet gefunden. Wir berichten hier von der Herstellung, den Eigenschaften und Anwendungen chemisch stabiler interner Diazopeptide. Peptidylphosphoranylidenester und ‐amide reagieren mit Triflylazid hauptsächlich zu neuartigen 4,5‐disubstituierten 1,2,3‐Triazolylpeptiden. Nonaflylazid hingegen liefert Diazopeptide, die als Amide bei pH 1–14 und als Ester bei pH 1–8 chemisch stabil sind. Somit sind durch Festphasenpeptidsynthese hergestellte Diazopeptide auch während der finalen Entschützung mit 95 % Trifluoressigsäure stabil. Diazopeptide mit der Erkennungssequenz von Caspase‐3 wurden als spezifische, kovalente und irreversible Inhibitoren dieses Enzyms bei niedrigen nanomolaren Konzentrationen identifiziert. Ein fluoreszierendes Diazopeptid drang in lebende Zellen ein und ermöglichte mikroskopische Visualisierung und Quantifizierung von Apoptose durch Durchflusszytometrie. Diazopeptide stellen somit eine neue Klasse aktivitätsbasierter Sonden und Enzyminhibitoren zum Einsatz in der chemischen Biologie und medizinischen Chemie dar.

  • Open Access

    Chemically Stable Diazo Peptides as Selective Probes of Cysteine Proteases in Living Cells

    by Juliane Wahl, Ahsanullah Ahsanullah, Hana Zupan, Franziska Gottschalk, Andreas Nerlich, Christoph Arkona, Andreas C. Hocke, Bettina G. Keller, Jörg Rademann

    Diazo peptides have been described earlier, however, due to their high reactivity have not been broadly used until today. Here, we report the preparation, properties, and applications of chemically stable internal diazo peptides. Peptidyl phosphoranylidene‐esters and amides were found to react with triflyl azide primarily to novel 3,4‐disubstituted triazolyl‐peptides. Nonaflyl azide instead furnished diazo peptides, which are chemically stable from pH 1–14 as amides and from pH 1–8 as esters. Thus, diazo peptides prepared by solid phase peptide synthesis were stable to final deprotection with 95 % trifluoroacetic acid. Diazo peptides with the recognition sequence of caspase‐3 were identified as specific, covalent, and irreversible inhibitors of this enzyme at low nanomolar concentrations. A fluorescent diazo peptide entered living cells enabling microscopic imaging and quantification of apoptotic cells via flow cytometry. Thus, internal diazo peptides constitute a novel class of activity‐based probes and enzyme inhibitors useful in chemical biology and medicinal chemistry.


  • Open Access

    Author Correction: Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins

    by Umer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, Maren Mieth, Amira Atef, Thomas Rudolf, Christoph Arkona, Timo Trenkner, Christoph Böttcher, Kai Ludwig, et al.

  • Open Access

    Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins

    by Umer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, Maren Mieth, Amira Atef, Thomas Rudolf, Christoph Arkona, Timo Trenkner, Christoph Böttcher, Kai Ludwig, et al.

    Pneumolysin (PLY) is a cholesterol-dependent cytolysin (CDC) from Streptococcus pneumoniae, the main cause for bacterial pneumonia. Liberation of PLY during infection leads to compromised immune system and cytolytic cell death. Here, we report discovery, development, and validation of targeted small molecule inhibitors of PLY (pore-blockers, PB). PB-1 is a virtual screening hit inhibiting PLY-mediated hemolysis. Structural optimization provides PB-2 with improved efficacy. Cryo-electron tomography reveals that PB-2 blocks PLY-binding to cholesterol-containing membranes and subsequent pore formation. Scaffold-hopping delivers PB-3 with superior chemical stability and solubility. PB-3, formed in a protein-templated reaction, binds to Cys428 adjacent to the cholesterol recognition domain of PLY with a KD of 256 nM and a residence time of 2000 s. It acts as anti-virulence factor preventing human lung epithelial cells from PLY-mediated cytolysis and cell death during infection with Streptococcus pneumoniae and is active against the homologous Cys-containing CDC perfringolysin (PFO) as well.